|
Two River Group Holdings is a New York-based venture capital firm and merchant bank focused on the life science sector. It specializes in investments in life science, biotechnology, and in firms focused on developing preventative and therapeutic technologies for a broad spectrum of disease areas including oncology, cardiovascular disease, neurological disorders, and companion animal health care.〔("Company Overview of Two River Group Holdings, LLC" ), ''Businessweek''. Retrieved on 26 June 2013.〕 Two River was founded in September 2004 by partners Joshua Kazam,〔("Joshua A. Kazam" ), ''Businessweek''. Retrieved on 26 June 2013.〕 Peter Kash, David Tanen〔("David M. Tanen" ), ''Businessweek''. Retrieved on 26 June 2013.〕 and Benjamin Bernstein.〔("Benjamin Bernstein" ), ''Businessweek''. Retrieved on 26 June 2013.〕 Dr. Arie Belldegrun joined the firm in 2008 as chairman and partner.〔("Dr. Arie S. Belldegrun, MD, FACS Joins Two River Group Holdings as Chairman and Partner" ). ''Reuters''. 29 April 2008. Retrieved 26 June 2013.〕 The firm has offices in New York City and Los Angeles. ==Portfolio== Two River has invested in the following life science companies:〔("Portfolio" ), ''Two River''. Retrieved on 29 April 2014.〕 *Arno Therapeutics (OTCBB: (ARNI )) - Arno is a clinical stage biopharmaceutical company that is developing innovative products for the treatment of cancer. *Edgemont Pharmaceuticals - Edgemont is a privately held pharmaceutical company with a primary focus and expertise in the field of neuroscience. Edgemont is committed to the development of novel drug formulations and new therapies that can improve patient care. *Kite Pharma (NASDAQ: (KITE )) - Kite is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient's own immune system to fight tumor cells. *Capricor Therapeutics (formerly Nile Therapeutics) (OTCBB: (CAPR )) - Capricor is a clinical stage biopharmaceutical company developing innovative products for the treatment of cardiovascular disease, with an initial focus on heart failure. *Velcera (acquired by Perrigo) - Velcera develops pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Two River」の詳細全文を読む スポンサード リンク
|